Biotech8 months ago
UCB Receives Approval from the EMA for its Treatment against Hidradenitis Suppurativa
The European Medicines Agency (EMA) is close to authorizing UCB's new treatment, Bimzelx, for hidradenitis suppurativa. The positive assessment from the Chmp suggests it could be...